Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: 5% MINOXIDIL: Minoxidil Dose-5%
Frequency-Twice Daily
Route- Topical application over the scalp
Follow up- 3weeks, 6weeks,9weeks, 12weeks
Duration of study- 12 weeks after completion of
Sponsors
ERA S LUCKNOW MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: All consenting male patients in the age group of 20â??50 years with AGA stage IIâ??VI Norwood-Hamilton classification visiting in dermatology OPD.
Exclusion criteria
Exclusion criteria: 1.Patients who have taken any form of treatment in past three months. 2.Patient with a history of hypersensitivity to minoxidil. 3.Patient with a history of bleeding disorders, on anticoagulants medications (aspirin, warfarin, heparin) and and with positive viral markers. 4.Patients with active infection at local site, nonpatterned alopecia, keloidal tendency, history of psoriasis, lichen planus and vitiligo.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢To trichoscopically assess and compare the effectiveness of 5% minoxidil alone and its combination with platelet rich plasma therapy.Timepoint: Baseline,3 Weeks,6 Weeks,9 Weeks,12 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢To trichoscopically evaluate the response in patient with 5% minoxidil monotherapy in individuals with AGA. â?¢To trichoscopically evaluate the synergistic effects of the combined therapy of 5% minoxidil & PRP in individuals with AGA. â?¢To analyze potential side effects during the course of treatment. Timepoint: Baseline,3 Weeks,6 Weeks,9 Weeks,12 weeks | — |
Countries
India
Contacts
Public ContactDR GOPAL PRASAD PODDAR
Eraâ??s Lucknow Medical College and Hospital
Outcome results
None listed